Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap Seroprevalence and Response in Pregnant Thai Women
NCT03498300Phase 1Completed
- Sponsor
- Mahidol University
- Start
- May 2018
- Primary completion
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tdap vaccine in pertussis (2 arms), sponsored by Mahidol University. Primary endpoint: Seroprevalence of Anti-pertussis Toxin Antibodies (Anti-PT IgG) at 4 months. Started May 2018; status: completed.
02
Drugs
tdap vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT03498300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03498300.